Join to View Full Profile
2000 Circle of Hope DrSalt Lake City, UT 84112
Phone+1 610-202-1638
Dr. Florou is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Vaia Florou is a medical Oncologist based in Salt Lake City, Utah. She completed her fellowship in Hematology and Medical Oncology at the University of Miami/Jackson Health System from 2016 to 2019. Prior to that, she completed her residency and served as a chief resident in Internal Medicine at Saint Peter's University Hospital/Rutgers Robert Wood Johnson Medical School between 2012 and 2016. She is an alumna of the University of Patras School of Medicine. Apart from clinical practice, Dr. Florou has contributed to numerous publications in recognized academic journals including the Journal of Gastrointestinal Oncology, Journal for Immunotherapy of Cancer, Cancers, Clinical Cancer Research, and Journal of Clinical Oncology. Her recently published works have been cited multiple times by other publications, indicating her active involvement in advancing her field.
Education & Training
University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 2016 - 2019
Saint Peter's University Hospital/Rutgers Robert Wood Johnson Medical SchoolChief Residency, Internal Medicine, 2015 - 2016- Saint Peter's University Hospital/Rutgers Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 2012 - 2015
University of Patras School of MedicineClass of 2010
Certifications & Licensure
UT State Medical License 2019 - 2026
ID State Medical License 2021 - 2025
MT State Medical License 2021 - 2025
NV State Medical License 2021 - 2025
WY State Medical License 2021 - 2025
NJ State Medical License 2015 - 2017
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Large scale multi-omic analysis identifies anatomic differences and immunogenic potential in subtypes of leiomyosarcoma.Galina Lagos, Roman Groisberg, Andrew Elliott, Don S Dizon, Andreas Seeber
Clinical Cancer Research. 2025-03-18 - A Review of Genomic Testing and SDH- Deficiency in Gastrointestinal Stromal Tumors: Getting to the GIST.Vaia Florou, Michelle F Jacobs, Ruth Casey, Denisse Evans, Becky Owens
Cancer Medicine. 2025-02-01 - A Phase 1b study of the OxPhos inhibitor ME-344 with bevacizumab in refractory metastatic colorectal cancer.Patrick M Boland, Heinz-Josef Lenz, Kristen K Ciombor, Vaia Florou, Michael J Pishvaian
Investigational New Drugs. 2025-02-01
Lectures
- Frameshift mutations (Fsindel) complement tumor mutation burden (TMB) in predicting survival after immune checkpoint inhibitors (ICI) in a pancancer analysis.2019 ASCO Annual Meeting - 6/1/2019
- Angiosarcoma treated with checkpoint inhibitors: A single-institution experience.2019 ASCO Annual Meeting - 6/1/2019
Grant Support
- Exploration of Novel Mutation Biomarkers to Repurpose EGFRi for Mutant KRAS Colorectal CancerUNIVERSITY OF UTAH2021–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
